Polymorphisms in Genes Involved in Folate Metabolism Modify the Association of Dietary and Circulating Folate and Vitamin B-6 with Cervical Neoplasia
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | TOMITA, Luciana Y. | |
dc.contributor.author | D'ALMEIDA, Vania | |
dc.contributor.author | VILLA, Luisa L. | |
dc.contributor.author | FRANCO, Eduardo L. | |
dc.contributor.author | CARDOSO, Marly A. | |
dc.contributor.groupauthor | BRINCA Study Grp | |
dc.date.accessioned | 2014-01-28T22:20:04Z | |
dc.date.available | 2014-01-28T22:20:04Z | |
dc.date.issued | 2013 | |
dc.description.abstract | High folate intake has been suggested as an important factor in cancer prevention; however, previous studies on the relation among folate intake, serum folate, and plasma homocysteine (hcy) are controversial. We conducted a hospital-based, case-control study in Brazil investigating associations between dietary and circulating vitamins B-6 and B-12 and folate, hcy, genotypes of folate-metabolizing enzyme methylenetetrahydrofolate reductase (MTHFR C677T, A1298C), 5-methyltetrahydrofolate-homocysteine methyltransferase (MTR A2756G), methionine synthase reductase (MTRR A66G), and reduced folate carrier (RFC1 G80A) and risk of cervical intraepithelial neoplasia (CIN) grades 1 (CIN1), 2 (CIN2), and 3 (CIN3). The study was composed by 453 controls, 140 CIN1, 126 CIN2, and 231 CIN3. We investigated the joint effects of genetic variants of folate-related genes using genetic risk scores (GRSs) by summing the number of risk alleles for CIN1 and CIN2+ (CIN2 and CIN3 cases). The OR (95% CI) for CIN1 and CIN2+ per each risk allele were 1.29 (1.01, 1.65) and 1.22 (1.01, 1.46), respectively. An association between folate intake and CIN2+ was observed only after stratification according to GRS: crude OR (95% CI) for lower folate intake and GRS >= 4 was 1.67 (0.92, 3.04) (P-trend < 0.001) compared with higher folate intake (above the median) and GRS <= 3. The CIN2+ risk of lower serum vitamin B-6 and GRS >= 4 was 2.14 (0.92, 5.02) (P-trend = 0.05) and lower serum folate (below the median) and GRS >= 4 was 0.49 (0.20, 1.17) (P-trend = 0.05) after adjustment for confounding variables and human papillomavirus infection. Our data suggest that polymorphisrns in genes related to folate metabolism modify the association of dietary and circulating folate and vitamin B-6 with cervical neoplasia. | |
dc.description.index | MEDLINE | |
dc.description.sponsorship | Sao Paulo State Research Foundation (FAPESP) [03/03013-4, 2007/53043-8] | |
dc.description.sponsorship | Brazilian National Counsel of Technological and Scientific Development (CNPq) [473043/03-3, 300167/97-0] | |
dc.description.sponsorship | FAPESP [02/11184-0] | |
dc.description.sponsorship | Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [BEX3775/05-4] | |
dc.description.sponsorship | CAPES [PRODOC 0091/08-1] | |
dc.identifier.citation | JOURNAL OF NUTRITION, v.143, n.12, p.2007-2014, 2013 | |
dc.identifier.doi | 10.3945/jn.113.182212 | |
dc.identifier.issn | 0022-3166 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/4014 | |
dc.language.iso | eng | |
dc.publisher | AMER SOC NUTRITION-ASN | |
dc.relation.ispartof | Journal of Nutrition | |
dc.rights | restrictedAccess | |
dc.rights.holder | Copyright AMER SOC NUTRITION-ASN | |
dc.subject.other | methylenetetrahydrofolate reductase mthfr | |
dc.subject.other | human-papillomavirus infection | |
dc.subject.other | total plasma homocysteine | |
dc.subject.other | multicentric case-control | |
dc.subject.other | methionine synthase ms | |
dc.subject.other | intraepithelial neoplasia | |
dc.subject.other | folic-acid | |
dc.subject.other | cancer-risk | |
dc.subject.other | serum micronutrients | |
dc.subject.other | dna methylation | |
dc.subject.wos | Nutrition & Dietetics | |
dc.title | Polymorphisms in Genes Involved in Folate Metabolism Modify the Association of Dietary and Circulating Folate and Vitamin B-6 with Cervical Neoplasia | |
dc.type | article | |
dc.type.category | original article | |
dc.type.version | publishedVersion | |
dspace.entity.type | Publication | |
hcfmusp.affiliation.country | Canadá | |
hcfmusp.affiliation.countryiso | ca | |
hcfmusp.author.external | TOMITA, Luciana Y.:Univ Fed Sao Paulo, Dept Prevent Med, Sao Paulo, Brazil | |
hcfmusp.author.external | D'ALMEIDA, Vania:Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil | |
hcfmusp.author.external | FRANCO, Eduardo L.:McGill Univ, Div Canc Epidemiol, Montreal, PQ, Canada | |
hcfmusp.author.external | CARDOSO, Marly A.:Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil | |
hcfmusp.citation.scopus | 18 | |
hcfmusp.contributor.author-fmusphc | LUISA LINA VILLA | |
hcfmusp.description.beginpage | 2007 | |
hcfmusp.description.endpage | 2014 | |
hcfmusp.description.issue | 12 | |
hcfmusp.description.volume | 143 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 24089416 | |
hcfmusp.origem.scopus | 2-s2.0-84888427333 | |
hcfmusp.origem.wos | WOS:000327571500019 | |
hcfmusp.publisher.city | BETHESDA | |
hcfmusp.publisher.country | USA | |
hcfmusp.relation.reference | Alberg AJ, 2000, CANCER EPIDEM BIOMAR, V9, P761 | |
hcfmusp.relation.reference | Barker J, 2011, J EUR ACAD DERMATOL, V25, P758, DOI 10.1111/j.1468-3083.2010.03932.x | |
hcfmusp.relation.reference | Berrington A, 2003, BIOSTATISTICS, V4, P423, DOI 10.1093/biostatistics/4.3.423 | |
hcfmusp.relation.reference | BLOCK G, 1994, AM J EPIDEMIOL, V139, P1190 | |
hcfmusp.relation.reference | Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2 | |
hcfmusp.relation.reference | Cardoso MA, 2010, CAD SAUDE PUBLICA, V26, P2059, DOI 10.1590/S0102-311X2010001100007 | |
hcfmusp.relation.reference | Carmel R, 2006, MODERN NUTR HLTH DIS, P470 | |
hcfmusp.relation.reference | Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516 | |
hcfmusp.relation.reference | Flatley JE, 2009, CANCER EPIDEM BIOMAR, V18, P2782, DOI 10.1158/1055-9965.EPI-09-0493 | |
hcfmusp.relation.reference | Fowler BM, 1998, CANCER EPIDEM BIOMAR, V7, P901 | |
hcfmusp.relation.reference | Goodman MT, 2000, CANCER, V89, P376, DOI 10.1002/1097-0142(20000715)89:2<376::AID-CNCR24>3.0.CO;2-O | |
hcfmusp.relation.reference | Goodman MT, 2001, CANCER EPIDEM BIOMAR, V10, P1275 | |
hcfmusp.relation.reference | Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471 | |
hcfmusp.relation.reference | Guerra-Shinohara EM, 2002, BJOG-INT J OBSTET GY, V109, P784, DOI 10.1016/S1470-0328(02)01307-1 | |
hcfmusp.relation.reference | Henao OL, 2005, INT J CANCER, V113, P991, DOI 10.1002/ijc.20695 | |
hcfmusp.relation.reference | Hernandez BY, 2003, CANCER CAUSE CONTROL, V14, P859, DOI 10.1023/B:CACO.0000003841.54413.98 | |
hcfmusp.relation.reference | Herrmann W, 2011, DTSCH ARZTEBL INT, V108, P249, DOI 10.3238/arztebl.2011.0249 | |
hcfmusp.relation.reference | Isotalo PA, 2000, AM J HUM GENET, V67, P986, DOI 10.1086/303082 | |
hcfmusp.relation.reference | Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500 | |
hcfmusp.relation.reference | Kanetsky PA, 1998, NUTR CANCER, V31, P31 | |
hcfmusp.relation.reference | Kim YI, 2000, NUTR REV, V58, P205 | |
hcfmusp.relation.reference | Kjellberg L, 2000, BRIT J CANCER, V82, P1332 | |
hcfmusp.relation.reference | Kleimbaum DG, 1998, LOGISTIC REGRESSION | |
hcfmusp.relation.reference | Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157 | |
hcfmusp.relation.reference | Kwasniewska A, 2002, EUR J GYNAECOL ONCOL, V23, P311 | |
hcfmusp.relation.reference | Lambropoulos AF, 2003, CANCER LETT, V191, P187, DOI 10.1016/S0304-3835(02)00675-4 | |
hcfmusp.relation.reference | Long SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052381 | |
hcfmusp.relation.reference | Luo YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046272 | |
hcfmusp.relation.reference | Mei Q, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-467 | |
hcfmusp.relation.reference | Moreno V, 2002, LANCET, V359, P1085, DOI 10.1016/S0140-6736(02)08150-3 | |
hcfmusp.relation.reference | Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641 | |
hcfmusp.relation.reference | Munoz N, 2002, LANCET, V359, P1093, DOI 10.1016/S0140-6736(02)08151-5 | |
hcfmusp.relation.reference | Myakishev MV, 2001, GENOME RES, V11, P163, DOI 10.1101/gr.157901 | |
hcfmusp.relation.reference | Parikh S, 2003, INT J CANCER, V105, P687, DOI 10.1002/ijc.11141 | |
hcfmusp.relation.reference | Piyathilake CJ, 2009, CANCER PREV RES, V2, P658, DOI 10.1158/1940-6207.CAPR-08-0175 | |
hcfmusp.relation.reference | Piyathilake Chandrika J, 2007, Ethn Dis, V17, pS2 | |
hcfmusp.relation.reference | Plummer M, 2003, CANCER CAUSE CONTROL, V14, P805, DOI 10.1023/B:CACO.0000003811.98261.3e | |
hcfmusp.relation.reference | Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359 | |
hcfmusp.relation.reference | Rozen R, 1997, THROMB HAEMOSTASIS, V78, P523 | |
hcfmusp.relation.reference | Rusch TL, 2003, P SOC PHOTO-OPT INS, V4966, P138, DOI 10.1117/12.483474 | |
hcfmusp.relation.reference | Sedjo RL, 2003, CANCER CAUSE CONTROL, V14, P319, DOI 10.1023/A:1023981505268 | |
hcfmusp.relation.reference | Sedjo RL, 2003, NUTRITION, V19, P497, DOI 10.1016/S0899-9007(02)01096-1 | |
hcfmusp.relation.reference | Shane B, 2008, FOOD NUTR B S2, V29, pS7 | |
hcfmusp.relation.reference | Shane B, 2008, FOOD NUTR BULL, V29, pS5 | |
hcfmusp.relation.reference | Shannon J, 2002, CANCER CAUSE CONTROL, V13, P691, DOI 10.1023/A:1020289618161 | |
hcfmusp.relation.reference | SHARMA SK, 1992, J CHROMATOGR-BIOMED, V578, P45, DOI 10.1016/0378-4347(92)80223-D | |
hcfmusp.relation.reference | Shekari M, 2008, ARCH GYNECOL OBSTET, V278, P517, DOI 10.1007/s00404-008-0623-6 | |
hcfmusp.relation.reference | Sohn KJ, 2009, INT J CANCER, V124, P1999, DOI 10.1002/ijc.24003 | |
hcfmusp.relation.reference | Szklo M., 2000, EPIDEMIOLOGY BASICS | |
hcfmusp.relation.reference | Thomson SW, 2000, NUTR CANCER, V37, P128, DOI 10.1207/S15327914NC372_2 | |
hcfmusp.relation.reference | Thomson SW, 2000, NUTRITION, V16, P411, DOI 10.1016/S0899-9007(00)00284-7 | |
hcfmusp.relation.reference | Tomita LY, 2010, INT J CANCER, V126, P703, DOI 10.1002/ijc.24793 | |
hcfmusp.relation.reference | Tong SY, 2011, CANCER CAUSE CONTROL, V22, P63, DOI 10.1007/s10552-010-9675-6 | |
hcfmusp.relation.reference | Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5 | |
hcfmusp.relation.reference | Ueland PM, 2001, TRENDS PHARMACOL SCI, V22, P195, DOI 10.1016/S0165-6147(00)01675-8 | |
hcfmusp.relation.reference | VANEENWYK J, 1992, CANCER EPIDEM BIOMAR, V1, P119 | |
hcfmusp.relation.reference | Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F | |
hcfmusp.relation.reference | Wang LN, 2006, EUR J CANCER, V42, P3206, DOI 10.1016/j.ejca.2006.04.022 | |
hcfmusp.relation.reference | Weinstein SJ, 2001, CANCER CAUSE CONTROL, V12, P317, DOI 10.1023/A:1011290103779 | |
hcfmusp.relation.reference | WHO, 2002, WHO TECHN REP SER, V916 | |
hcfmusp.relation.reference | Wideroff L, 1998, NUTR CANCER, V30, P130 | |
hcfmusp.relation.reference | Willett W., 1998, NUTR EPIDEMIOLOGY | |
hcfmusp.relation.reference | Yang QH, 2009, CANCER EPIDEM BIOMAR, V18, P1439, DOI 10.1158/1055-9965.EPI-08-0908 | |
hcfmusp.relation.reference | Yeo ASS, 2000, NUTR CANCER, V38, P141, DOI 10.1207/S15327914NC382_1 | |
hcfmusp.relation.reference | Ziegler RG, 2002, J NUTR, V132, p2345S | |
hcfmusp.remissive.sponsorship | CAPES | |
hcfmusp.remissive.sponsorship | CNPq | |
hcfmusp.remissive.sponsorship | FAPESP | |
hcfmusp.scopus.lastupdate | 2024-04-12 | |
relation.isAuthorOfPublication | e9db2534-e0d7-4b2e-b4aa-c3be7faf01d5 | |
relation.isAuthorOfPublication.latestForDiscovery | e9db2534-e0d7-4b2e-b4aa-c3be7faf01d5 |
Arquivos
Pacote Original
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- art_VILLA_Polymorphisms_in_Genes_Involved_in_Folate_Metabolism_Modify_2013.PDF
- Tamanho:
- 561.05 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)